In this study, concomitant stimulation of DLBCL cells with IL-6 and IL-17A was shown to exert a synergistic effect on promoting the growth and increasing cell drug-resistance in vitro (Zhong et al., 2019). The gene discussed is IL6; the disease is diffuse large B-cell lymphoma.